3^rd International Conference on Rare Diseases and Orphan Drugs

Dear Esteemed Colleagues, Distinguished Guests, and Friends,

It is with great pleasure that I welcome you to the 3rd International Conference on Rare Diseases and Orphan Drugs, organized by Coalesce Research Group. This two-day conference, scheduled for October 27-28, 2025, in the dynamic city of Singapore, serves as a crucial platform for experts, stakeholders, and advocates to collaborate on advancing our understanding and treatment of rare diseases.

Under the theme of Advancing Frontiers: Breakthroughs in Rare Diseases and Orphan Drugs, we stand at an exciting intersection of traditional medical research and emerging technologies. As someone deeply involved in the application of artificial intelligence in medical diagnostics, I am particularly enthusiastic about exploring how these innovative technologies can accelerate our progress in rare disease detection, diagnosis, and treatment.

Rare diseases, while individually uncommon, collectively impact millions of lives worldwide. The challenges in this field are unique, from achieving accurate early diagnosis to developing targeted treatments. However, we are witnessing unprecedented opportunities for breakthrough solutions through the convergence of AI, advanced imaging technologies, and precision medicine.

This conference provides an invaluable opportunity to showcase cutting-edge research and foster collaborative innovation. We will explore various crucial topics, including novel diagnostic approaches, AI-enabled drug discovery, advanced imaging techniques, and patient-centered care strategies. By sharing our diverse expertise and experiences, we can identify new opportunities and forge powerful collaborations.

As the Dean of the School of Sciences at Woxsen University and someone who works at the intersection of technology and healthcare, I am particularly excited about the potential for cross-disciplinary discussions that this conference enables. Our gathering brings together experts from various fields – clinicians, researchers, technologists, and policy makers – creating a unique environment for innovative solutions to emerge.

I encourage all participants to actively engage in the sessions, share their insights, and build meaningful connections. Together, we can accelerate the pace of discovery and translate scientific innovations into real-world solutions for patients affected by rare diseases.

Let us make these two days count in our collective mission to advance rare disease research, develop transformative therapies, and bring hope to patients and families worldwide.

With warm regards,

Dr. Daya Shankar

Dean, School of Sciences

Woxsen University

Co-Chairperson, Centre of Excellence for Technology and Public Policy

Convenor-Institute Innovation Council, Ministry of Education, Government of India

The Journal of Diseases, Disorders & Treatments (JDDT), published by Scientific Research and Community (SRC), is an international open-access, peer-reviewed journal committed to disseminating high-quality research on diseases, disorders, and treatments. JDDT accepts diverse formats, including research articles, reviews, case reports, videos, and PowerPoint presentations, making knowledge accessible globally.

The journal covers a wide range of topics, such as emerging Diseases, all studies of viruses, Emerging Diseases, Airborne Disease, Biological Contamination, Blood-Borne Disease, Coinfection, Pathology, Neglected Diseases, Tropical Disease, Waterborne Diseases, Foodborne Illness, Globalization And Disease, Human Microbiome Project, Infection Control, Clinical Physiology, Neurolysis, Celiac Plexus, Breast Conservative Surgery, Alzheimer’s Disease, Neurodegeneration, Pharmacotherapy, Monkeypox, Food Allergy, HIV/Aids, Malaria, Influenza, Tuberculosis, Diabetes, Digestive Diseases, Kidney Disease, Weight Management, Urologic Diseases, Liver Disease, Endocrine Diseases, Diet & Nutrition, Diagnostic Tests, Blood Diseases, Disorders & Treatments for all kind of diseases and other clinical & Medical disorders etc and is indexed in major databases with DOI activation for all articles.

A processing and publication fee of USD $519 is applicable for accepted submissions.

For further details, visit: https://www.onlinescientificresearch.com/journal-of-diseases-disorders-treatments-home-jddt.php

You can submit your article through Online: http://www.onlinescientificresearch.com/submit-online.php

Email: diseases@onlinescientificresearch.info

Dear Esteemed Colleagues, Distinguished Guests, and Friends,

With great enthusiasm I welcome you to the 3rd International Conference on Rare Diseases and Orphan Drugs (Rare Diseases 2025), proudly organized by the Coalesce Research Group. This conference will be held on October 27–28, 2025 in Singapore, a city acknowledged for their rich culture.

The theme for this year will be, "Advancing Frontiers: Breakthroughs in Rare Diseases and Orphan Drugs," which reflects our shared commitment to addressing the challenges faced by patients, caregivers, and healthcare providers in this field. Over two impactful days, we will engage in insightful discussions, share ground-breaking research, and explore strategies that have the potential to transform lives.

This conference serves as a critical gathering point for leaders in research, medicine, patient advocacy, and policy-making. Together, we will explore topics such as novel diagnostic tools, advancements in gene therapies, personalized medicine, and the integration of patient perspectives into care and research. By sharing our experiences and expertise, we aim to not only deepen our collective knowledge but also strengthen collaborations that can accelerate breakthroughs in this space.

It is my privilege to extend my warmest welcome to all of you as we embark on this important journey together. Let us seize this moment to collaborate, innovate, and bring hope to patients and families worldwide.

With Regards,
Dr. Gotabhaya Ranasinghe